Open AccessChemotherapy modulates CDK4/6 inhibitors resistance in metastatic breast cancer by Rb1 mutations: a case report and literature review
Author(s) -
Lu Gao,
XiaBo Shen,
Libin He,
Jiayi Wu,
Yiyuan Liu,
Xiaojia Wang,
Xiying Shao
Publication year - 2022
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-22-52
Subject(s) - cancer research , breast cancer , cell cycle , eribulin , palbociclib , estrogen receptor , cyclin d1 , retinoblastoma protein , cyclin dependent kinase 4 , cancer , metastatic breast cancer , medicine , oncology , cyclin dependent kinase 2
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom